𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China

✍ Scribed by Guangbi Yao; Xiaqiu Zhou; Daozheng Xu; Baoen Wang; Hong Ren; Jessica Liu; Dong Xu; Laurie MacDonald


Book ID
107593717
Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
318 KB
Volume
1
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Adefovir-based combination therapy with
✍ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV ΓΎ LAM therapy